Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

May toxicity of amiodarone be prevented by antioxidants? A cell-culture study

  • Ahmet Baris Durukan1Email author,
  • Beril Erdem2,
  • Elif Durukan3,
  • Handan Sevim2,
  • Tugce Karaduman2,
  • Hasan Alper Gurbuz1,
  • Aylin Gurpinar2 and
  • Cem Yorgancioglu1
Journal of Cardiothoracic Surgery20127:61

DOI: 10.1186/1749-8090-7-61

Received: 19 April 2012

Accepted: 28 June 2012

Published: 28 June 2012

Abstract

Background

Atrial Fibrillation is the most common arrhythmia encountered following cardiac surgery. The most commonly administered drug used in treatment and prophylaxis is amiodarone which has several toxic effects on major organ functions. There are few clinical data concerning prevention of toxic effects and there is no routinely suggested agent. The aim of this study is to document the cytotoxic effects of amiodarone on cell culture media and compare the cytoprotective effects of commonly used antioxidant agents.

Methods

L929 mouse fibroblast cell line was cultured and 100,000 cells/well-plate were obtained. First group of cells were treated with increasing concentrations of amiodarone (20 to 180 μM) alone. Second and third group of cells were incubated with one-fold equimolar dose of vitamin C and N-acetyl cysteine prior to amiodarone exposure. The viability of cells were measured by MTT assay and the cytoprotective effect of each agent was compared.

Results

The cytotoxicity of amiodarone was significant with concentrations of 100 μM and more. The viabilities of both vitamin C and N-acetyl cysteine treated cells were higher compared to untreated cells.

Conclusions

Vitamin C and N-acetyl cysteine are commonly used in the clinical setting for different purposes in context of their known antioxidant actions. Their role in prevention of amiodarone induced cytotoxicity is not fully documented. The study fully demonstrates the cytoprotective role of both agents in amiodarone induced cytotoxicity on cell culture media; more pronounced with vitamin C in some concentrations. The findings may be projectile for further clinical studies.

Keywords

Amiodarone Cytotoxicity Cell culture Vitamin C n-acetyl cysteine

Background

Innumerous studies have been published enclosing treatment and prophylaxis of postoperative atrial fibrillation (AF). Amiodarone is a type 3 anti-arrhythmic agent frequently used for medical cardioversion with varying protocols [1]. It has potential serious side effects in a wide spectrum including photosensitivity, pulmonary toxicity, polyneuropathy, gastrointestinal upset, bradycardia, torsades de pointes (rare), hepatic toxicity, thyroid dysfunction and ocular complications [24].

Currently, there are no clinical agents available for prevention of amiodarone induced toxicity. The aim of this study is to underline the toxic effects of amiodarone in cell culture media and propose potential antioxidant agents for clinical use in terms of preventing amiodarone induced toxicity.

Methods

L929 mouse fibroblastic cell line was plated in 96-well culture plates (Greiner Bio-One, Germany) at an initial density of 100,000 cells/well and incubated in Dulbecco's Modified Eagle Medium/Ham’s F12 (DMEM/F12) (Biochrom AG, Germany) supplemented with 10% fetal bovine serum (FBS) (Biochrom AG, Germany). Following 24 hours of incubation period, the culture medium was removed. The untreated cells were considered as controls. Then, amiodarone hydrochloride (Cordorone®, 150 mg/3 ml, Sanofi-Synthalebo, İstanbul, Turkey) was prepared in nine different concentrations (20 μM, 40 μM, 60 μM, 80 μM, 100 μM, 120 μM, 140 μM, 160 μM, 180 μM). To obtain the studied concentrations, amiodarone was dissolved in the cell culture media. In the first group, the cells were treated with amiodarone alone with the mentioned concentrations. Simultaneously, fresh medium containing one-fold the equimolar dose of amiodarone concentrations of vitamin C (Vitabiol-C®,500 mg/5 ml, İbrahim Etem Ulugay İlaç Sanayi Türk A.Ş, İstanbul Turkey) and N-acetyl cysteine (NAC) (Asist®, 100 mg/ml, Hüsnü Arsan İlaçları A.Ş, İstanbul, Turkey) were prepared. In the second and third groups, in order to study the potential antioxidant effects, cells were preincubated with vitamin-C and NAC for two hours, and then amiodarone was added. After 24 hours of incubation, cell viabilities of the three groups were assessed by the MTT assay and compared with non-pretreated cells. Cell viability was expressed as the relative formazan formation in treated samples as compared to control cells [(A570 treated cells/A570 control cells) x 100%].

Determination of cell line

L929, a murine aneuploid fibrosarcoma cell line was employed in this study, because it is an established cell line allowing reproducibility of the results, and cells multiply rapidly with an unlimited life span. It is used commonly for multiple purposes including biocompatibility and cytotoxicity tests [5, 6].

Determination of amiodarone concentrations

The concentrations used in cell culture was based on tissue concentration studies. In a survey of 122 patients chronically treated with amiodarone treatment, serum concentrations were measured as 0.4-3.3 (mean 1,7) mg/l, which corresponds to 0.58-4.81 (mean 2.47) μM. Concentrations in myocardial tissue was approximately 30 times the serum concentration (mean 74.1 μM), whereas up to 100 times (247 μM) in various organs [7]. In end stage heart failure, pharmacodynamics differ. Serum concentrations were measured as 0.68 μg/ml which corresponds to 1 μM. Amiodarone concentrations in myocardial tissue was approximately 15 times the serum concentration (15 μM), whereas 150 times (150 μM) in epicardial fat [8]. Similar concentrations used in this study were also used in other cell culture studies made with amiodarone[9].

MTT assay

MTT assay is a standardized procedure defining viability. This colorimetric method assesses the ability of viable cells to form MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) formazan by the mitochondrial enzyme succinate dehydrogenase. It was originally defined by Carmaichael et al. to assess cytotoxicity [10].

To assess viability, at the end of the designed incubation period, the culture medium was replaced with 200 μl medium containing 0.5 mg/ml MTT and plates were incubated for 3 hours at 37°C. The medium was then removed and replaced with 200 μl of 0.04 M HCl/isopropanol which solubilizes the converted purple dye in culture plates. The absorbance was measured on a spectrophotometer microplate reader (μQuantTM, Biotek® Instruments Inc, USA) at a wavelength of 570 nm. Each experiment was repeated 6 times seperately.

Statistical analysis

Statistical analyses were performed using SPSS software for Windows (version 17.0, Statistical Package for the Social Sciences Inc, Chicago, IL, USA). The viability of cells in different amiodarone doses were compared using repeated measures variance analysis. To compare viability in each concentration according to treatment groups, Kruskal Wallis test was used. In cases of significant difference “bonferoni adjusted Mann–Whitney u test” was used to explore the more efficient group.

Results

When cytotoxicity of amiodarone in different doses was examined, upto 80 μM concentration, decrease in viability was not significant (p < 0.0001). The cytotoxic effects appeared with concentrations of 100 μM and more (p < 0.01). In these concentrations both vitamin C and NAC had cytoprotective effects and lead to increases in viability (p < 0.016) (Table 1). In concentrations of 100, 140 and 180 μM vitamin C and NAC had equal protective effects, whereas in concentrations of 120 and 160 μM, vitamin C was more efficient (p < 0.016).
Table 1

The mean cell viabilities (%) after treatment with amiodorane alone and with antioxidant agents

 

Cell viability % (Mean ± SD)

Concentration

Amiodarone

Amiodarone + Vitamin Ca

Amiodarone + NACa

p*

20 μM

117.10 ± 50.75

131.31 ± 36.62

133.86 ± 38.91

0.884

40 μM

130.49 ± 48.70

122.12 ± 24.27

91.83 ± 41.86

0.166

60 μM

97.73 ± 48.08

108.25 ± 16.85

133.65 ± 28.12

0.172

80 μM

81.39 ± 64.45

122.00 ± 19.94

120.34 ± 52.70

0.414

100 μM

59.41 ± 16.43

128.43 ± 30.94

108.74 ± 39.04

0.011

120 μM

26.66 ± 7.40

116.63 ± 23.81

74.93 ± 26.31

0.001

140 μM

19.63 ± 6.81

88.11 ± 29.38

80.33 ± 43.47

0.003

160 μM

16.92 ± 6.46

111.55 ± 24.02

70.18 ± 23.15

0.001

180 μM

14.91 ± 4.32

68.52 ± 25.39

48.58 ± 12.21

0.002

a Vitamin C and NAC were added at one-fold equimolar dose of amiodarone concentrations.

*Kruskal-Wallis test.

NAC: N-acetyl cysteine.

Discussion

Atrial fibrillation is the most commonly encountered rhythm disorder following cardiac surgery. Amiodarone is a very effective agent used in treatment and prophylaxis of postoperative AF [2, 1113]. The risk of toxicity increases with increasing plasma concentrations. Due to its high liposolubility, it accumulates in adipose tissue and highly perfused organs such as lungs, liver and spleen. This tendency also contributes to its toxic effects besides from cellular mechanisms of toxicity [14].

Free radical formation, direct cytotoxicity, development of lysosomal phospholipidosis and membrane destabilization are the documented possible cellular mechanisms of toxicity, but it is known that the predominant molecular mechanism of amiodarone induced cell death is the trigger caused by oxidative damage [9]. The oxidative stress normally results either due to increased production of reactive oxygen species or decreased antioxidant capacity of cells, of which former is the mechanism in case of amiodarone induced cytotoxicity. Since it is not possible to prevent the development of oxidative stress itself, it would be rational to increase the cellular levels of antioxidants, which is the hypothesis for eveluating the use of antioxidant agents to prevent amiodarone induced cytotoxicity in this study.

To date, there are few data concerning prevention of amiodarone induced cytotoxicity. In some cell culture and experimental animal studies antioxidants, particularly vitamin E was employed and was found to be effective in increasing viability following exposure to toxic doses of amiodarone. Golli-Bennour et al. very clearly demonstrated the cytoprotective role of vitamin E on human cell culture lines [9]. Boldt et. al and Card JW et. al reported attenuation of amiodarone induced pulmonary fibrosis by vitamin E in experimental animal models [15, 16]. Agoston et al. studied the antioxidant effect of dietary vitamin E on rat hepatocytes concurrent with amiodarone administration and showed reduction of lysosomal phospholipidosis [17]. Those studies are valuable, since they demonstrate the possible effectiveness of antioxidants for prevention of amiodarone toxicity. But to our knowledge very few studies with vitamin C and NAC were carried out in order to prevent amiodarone induced cytotoxicity.

Vitamin C mediates its antioxidant action possibly via scavenging reactive oxygen and nitrogen species including free radicals such as hydroxyl radicals, superoxide anion, nitrogen dioxide and aqueous radicals. It also acts on nonradical species such as ozone, hypochlorus acid, singlet oxygen, nitroxide, peroxynitrite and nitrosating species. Morover, vitamin C is capable of regenerating small molecule antioxidants such as α-tocopherol, glutathione, urate and β-karotene from their respective radical species [18, 19]. At the cellular level, vitamin C prevents the unwanted effects of reactive oxygen species directly by causing an increase in cellular antioxidant enzyme activities and indirectly by reducing oxidized form of vitamin E and glutathione [19]. It is obvious that vitamin-C counteracts on multiple levels of cellular oxidative stress, which we think is the key feature in prevention of amiodarone toxicity.

N-acetyl cysteine has a similar mechanism of antioxidant action which is mediated either directly by scavenging reactive oxygen species or indirectly by production of glutathione [20]. The cysteine component of NAC combines with glutamate and glycine, the precursors in the production of glutathione, in which cysteine is the rate limiting step. Glutathione itself is the most generic antioxidant in the body [21]. Lee et al. demonstrated the preventive role of NAC against contrast induced nephrotoxicity measured by MTT analysis in a similarly designed study on human embryonic kidney cells [20]. We also believe that, NAC prevents amiodarone induced cytotoxicity via glutathione pathway, but molecular analysis should be made for certainity.

When clinical side of the unknown equation of amiodarone induced cytotoxicity is explored, the additive effect of inflammation and oxidative stress which play role in development of arrhythmias should also be considered. Particularly inflammatory response associated with cardiopulmonary bypass is a critical cornerstone following cardiac surgery. Although not fully documented, clinical use of antioxidants may also have favorable effects in this clinical setting. Rodrigo et al. reviewed use of antioxidants for prevention of AF and suggested use of vitamin E and vitamin C hypothesizing that their use not only would minimize the risk of post-cardiac surgery AF, but also increase its treatment success [22]. Carnes et al. reported antioxidant role of vitamin C and documented decreased risk of postoperative AF in patients given prophylactic preoperative and postoperative vitamin C [23]. Similarly, Korantzopaulos et al. studied the effects of vitamin C on recurrence of electrically cardioverted persistent AF and found decreased incidence with vitamin C [24]. In none of the studies, their role in amiodarone treatment was noted. Different from those findings, our study documented the preventive role of vitamin C against amiodarone cytotoxicity in cell culture media.

When NAC is considered in clinical use, Ozaydin et al. reported NAC to have favorable effects in prevention of postoperative AF [25]. They did not use NAC together with amiodarone. Serviddio et al. studied liver toxicity during amiodarone administration in an animal experiment and documented that NAC completely prevented mitochondrial respiratory chain dysfunction and membrane phospholipid damage caused by amiodarone [26]. In cell culture, we also found that NAC prevents amiodarone induced cytotoxicity.

Our findings are valuable in terms of defining cytotoxic effects of amiodarone which occur only in moderate to high doses. In lower doses (80 μM or less), the toxicity is not noted with amiodarone in our study.

The viabilities were measured to be more than 100% in some measurements. There are several explanations for that. The control group is the untreated cells whose spectrophotometric measurements were made after the first 24 hours of incubation period. But for amiodarone alone and amiodarone with antioxidant treated cells, the measurements were made following a second 24 hours of incubation period. The cytotoxic effects of amiodarone began above 100 μM concentration. Moreover, the culture media in which the agents were dissolved, possibly served as a suitable medium for proliferation during the second 24 hours period in lower concentrations.

Conclusions

The findings of the study demonstrate that vitamin C and N-acetyl cysteine are thought to be effective in terms of decreasing cellular cytotoxicity of amiodarone. The ease and rapidness of using cell culture media for cytoxicity tests are worth noting. Non-clinical, laboratory based studies usually are incapable of answering clinical questions and direct projections are hardly made. But, since the agents used in this study for prevention of cytotoxicity are commonly administered, almost naive agents used for multiple purposes in the routine clinical setting, the findings may be useful for further clinical studies.

Limitations

L929 is a very frequently used and reliable cell line employed in cytotoxicity tests, so it was the choice of cell line in our study. But human cell lines could also be used for more reliable analysis. Especially, human hepatic and renal cell lines could provide a better understanding of antioxidant behavior of vitamin-C and NAC in terms of prevention of amiodarone induced cytotoxicity, and easier future projections could be made. A similar study with vitamin E was performed by Golli-Bennour on human cell culture lines, and protective effects were demonstrated [9]. But L929 can be considered as a standard cell line employed in cytotoxicity tests, so the results are considered as reliable.

The results could also be supported with further analyses like measurement of lipid peroxidation products which shows the oxidative status of amiodarone treated cells.

Authors information

Durukan AB: Specialist in cardiovascular surgery, Making PhD in Biology, particularly dealing with cell culture and stem cells. The standpoint of the study is the look to cell culture from a cardiovascular surgeon’s eye as an easy tool readily applicable for clinical studies.

Abbreviations

AF: 

Atrial fibrillation

NAC: 

N-acetyl cysteine

MTT: 

(3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide).

Declarations

Acknowlegements

None

Authors’ Affiliations

(1)
Department of Cardiovascular Surgery, Medicana International Ankara Hospital, Eskisehir Yolu Uzeri, Sogutozu
(2)
Department Of Biology, Hacettepe University, Faculty Of Science, Beytepe
(3)
Department Of Public Health, Baskent University Medical Faculty

References

  1. Zebis LR, Christensen T, Kristiansen IS, Hjortdal VE: Amiodarone cost effectiveness in preventing atrial fibrillation after coronary artery bypass graft surgery. Ann Thorac Surg. 2008, 85: 28-33. 10.1016/j.athoracsur.2007.07.060.View ArticlePubMedGoogle Scholar
  2. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Heuzey JL, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S: ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary. Circulation. 2006, 114: 700-752.View ArticleGoogle Scholar
  3. Jackevicius CA, Tom A, Essebag V, Eisenberg MJ, Rahme E, Tu JV, Humphries K, Behlouli H, Pilote L: Population-level ıncidence and risk factors for pulmonary toxicity associated with amiodarone. Am J Cardiol. 2011, 108: 705-710. 10.1016/j.amjcard.2011.04.024.View ArticlePubMedGoogle Scholar
  4. Rizzioli E, Incasa E, Gamberini S, Savelli S, Zangirolami A, Tampieri M, Manfredin R: Acute toxic hepatitis after amiodarone intravenous loading. Am J Emerg Med. 2007, 25: 1082-e1-1082.e4View ArticlePubMedGoogle Scholar
  5. Cohen BI, Pagnillo BS, Musikant BL, Deutsch AS: An in vitro study of the cytotoxicity of two root canal sealers. J Endod. 2000, 26: 228-229. 10.1097/00004770-200004000-00008.View ArticlePubMedGoogle Scholar
  6. Beriat GK, Akmansu SH, Gurpinar OA, Onur MA, Alhan A: The cytotoxic effect of nasodren nasal spray (Cyclamen Europaeum Extract) in L929 fibroblastic cell culture. Turkiye Klinikleri J Med Sci. 2011, 31: 287-296. 10.5336/medsci.2009-15898.View ArticleGoogle Scholar
  7. Haffajee CI, Love JC, Canada AT, Lesko LJ, Asdourian G, Alpert JS: Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias. Circulation. 1983, 67: 1347-1355. 10.1161/01.CIR.67.6.1347.View ArticlePubMedGoogle Scholar
  8. Candinas R, Frielingsdorf J, Carrel T, Turina M, Follath F: Myocardial amiodarone concentrations after short and long-term treatment in patients with end-stage heart failure. Eur J Clin Pharmacol. 1998, 53: 331-336. 10.1007/s002280050388.View ArticlePubMedGoogle Scholar
  9. Golli-Bennour EE, Bouslimi A, Zouaoui O, Achour A, Bacha H: Cytotoxicity effects of amiodarone on cultured cells. Exp Toxicol Pathol. 2010, 10.1016/j.etp.2010.10.008.Google Scholar
  10. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 1987, 47: 936-942.PubMedGoogle Scholar
  11. Echadidi N, Pibarot P, O’Hara G, Mathieu P: Mechanisms, prevention and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol. 2008, 51: 793-801. 10.1016/j.jacc.2007.10.043.View ArticleGoogle Scholar
  12. Koniari I, Apostolakis E, Rogkakou C, Baikoussis NG, Dugenis D: Pharmacologic prophylaxis for atrial fibrillation following cardiac surgery: a systematic review. J Cardiothorac Surg. 2010, 5: 121-10.1186/1749-8090-5-121.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Workman AJ, Smith GL, Rankin AC: Mechanisms of termination and prevention of atrial fibrillation by drug therapy. Pharmacol Therap. 2011, 131: 221-241. 10.1016/j.pharmthera.2011.02.002.View ArticleGoogle Scholar
  14. Woklove N, Baltzan M: Amiodarone pulmonary toxicity. Can Resp J. 2009, 16: 43-48.Google Scholar
  15. Bolt MW, Racz WJ, Brien JF, Massey TE: Effects of vitamin E on cytotoxicity of amiodarone and N-desethylamiodarone in isolated hamster lung cells. Toxicology. 2001, 166: 109-118. 10.1016/S0300-483X(01)00451-6.View ArticlePubMedGoogle Scholar
  16. Card JW, Racz WJ, Brien JF, Massey TE: Attenuation of amiodarone-induced pulmonary fibrosis by vitamin E is associated with supression of transforming growth factor-beta 1 gene expression, but not prevention of mitochondrial dysfunction. J Pharmacol Exp Ther. 2003, 304: 277-283. 10.1124/jpet.102.043208.View ArticlePubMedGoogle Scholar
  17. Agoston M, Örsi F, Feher E, Hagyma K, Orosz Z, Blazovics A, Feher J, Vereckei A: Silymarin and vitamin E reduce amiodarone-induced lysosomal phospholipidosis in rats. Toxicology. 2003, 190: 231-241. 10.1016/S0300-483X(03)00188-4.View ArticlePubMedGoogle Scholar
  18. Carr AC, Frei B: Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr. 1999, 69: 1086-1107.PubMedGoogle Scholar
  19. Viswanatha-Swamy AH, Wangikar U, Koti BC, Thippeswamy AH, Ronad PM, Manjula DV: Cardioprotective effect of ascorbic acid on doxorubicin-induced myocardial toxicity in rats. Indian J Pharmacol. 2011, 43 (5): 507-511. 10.4103/0253-7613.84952.View ArticlePubMedPubMed CentralGoogle Scholar
  20. Lee HC, Sheu SH, Liu IH, Lee CC, Hsieh CC, Yen HW, Lai WT, Chang JG: Impact of short-duration administration of N-acetylcysteine, probucol and ascorbic acid on contrast-induced cytotoxicity. J Nephrol. 2012, 25: 56-62. 10.5301/JN.2011.7741.View ArticlePubMedGoogle Scholar
  21. Sansone RA, Sansone LA: Getting a Knack for NAC: N-Acetyl-Cysteine. Innov Clin Neurosci. 2011, 8: 10-14.Google Scholar
  22. Rodrigo R, Vinay J, Castillo R, Cereceda M, Asenjo R, Zamorano J, Araya J, Castillo-Koch R, Espinoza J, Larrain E: Use of vitamins C and E as a prophylactic therapy to prevent postoperative atrial fibrillation. Int J Cardiol. 2010, 138: 221-228. 10.1016/j.ijcard.2009.04.043.View ArticlePubMedGoogle Scholar
  23. Carnes CA, Chung MK, Nakayama T, Nakayama H, Baliga RS, Piao S, Kanderian A, Pavia S, Hamlin RL, McCarthy PM, Bauer JA, Van Wagoner DR: Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res. 2001, 89: E32-E38. 10.1161/hh1801.097644.View ArticlePubMedGoogle Scholar
  24. Korantzopoulos P, Kolettis TM, Kountouris E, Dimitroula V, Karanikis P, Pappa E, Siogas K, Goudevenos JA: Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation. Int J Cardiol. 2005, 102: 321-326. 10.1016/j.ijcard.2004.12.041.View ArticlePubMedGoogle Scholar
  25. Ozaydin M, Peker O, Erdogan D, Kapan S, Turker Y, Varol E, Ozguner F, Dogan A, İbrisim E: N-actylcysteine for the prevention of postoperative atrial fibrillation: a prospective randomized, placebo-controlled pilot study. Eur Heart J. 2008, 29: 625-631. 10.1093/eurheartj/ehn011.View ArticlePubMedGoogle Scholar
  26. Serviddio G, Bellanti F, Giudetti AM, Gnoni GV, Capitanio N, Tamborra R, Romano AD, Quinto M, Blonda M, Vendemiale G, Altomare E: Mitochondrial oxidative stress and respiratory chain dysfunction account for liver toxicity during amiodarone but not dronedarone administration. Free Radic Biol Med. 2011, 51: 2234-2242. 10.1016/j.freeradbiomed.2011.09.004.View ArticlePubMedGoogle Scholar

Copyright

© Durukan et al.; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.